FDA-Approved Fat-Dissolving Injections: What Is Actually Approved?

FDA-approved fat-dissolving injections exist, but the approved options are much more limited than many online advertisements suggest.

As of September 2026, the U.S. Food and Drug Administration recognizes Kybella and an approved generic deoxycholic acid injection for reducing the appearance of moderate-to-severe fat beneath the chin in adults. However, the FDA has not approved these injections for removing fat from the abdomen, thighs, arms, back, flanks, or other body areas.

Therefore, understanding the difference between an FDA-approved drug and an unapproved injection is essential before considering treatment.

Moreover, a product containing a familiar ingredient does not automatically have FDA approval. The approval applies to a specific drug, formulation, indication, and method of use.

What Fat Dissolving Injections Are FDA Approved?

The main FDA-approved fat-dissolving drug is Kybella, which contains deoxycholic acid.

The FDA originally approved Kybella in 2015. Later, in 2021, the agency approved a generic deoxycholic acid injection as therapeutically equivalent to Kybella.

Both products have the same approved purpose: to improve the appearance of moderate-to-severe fullness caused by submental fat in adults.

In everyday language, that means fat beneath the chin, often called a double chin.

However, FDA approval does not extend to other body areas.

Consequently, a clinic advertising deoxycholic acid injections for abdominal fat, thighs, upper arms, bra fat, or love handles is describing an unapproved use.

What Is Kybella?

Kybella is the brand name for a deoxycholic acid injection.

Deoxycholic acid occurs naturally in the body and helps break down dietary fat in the digestive system.

When a trained healthcare professional injects synthetic deoxycholic acid into the appropriate submental fat, the drug disrupts fat cell membranes. The body then gradually clears the cellular material.

Therefore, treatment can reduce the visible fullness beneath the chin.

However, Kybella is not a general weight-loss treatment.

It targets a relatively small, localized pocket of submental fat. Consequently, it does not replace diet, exercise, obesity treatment, or procedures intended for large-volume fat reduction.

What Is the Generic Deoxycholic Acid Injection?

The FDA approved a generic deoxycholic acid injection in 2021.

The agency determined that the approved generic met requirements for bioequivalence and therapeutic equivalence to Kybella.

Therefore, the phrase “FDA-approved fat-dissolving injections” can now technically refer to more than one approved product.

However, both rely on the same active drug, deoxycholic acid, and both share the same narrow treatment indication.

Additionally, FDA approval does not necessarily mean that every approved generic product is widely available at clinics or pharmacies at any given time.

Which Areas Can FDA-Approved Fat Dissolving Injections Treat?

The FDA-approved treatment area is the submental region beneath the chin.

That limitation matters.

Treatment Area	FDA-Approved Deoxycholic Acid Use?
Under the chin	Yes
Stomach	No
Thighs	No
Upper arms	No
Back fat	No
Flanks/love handles	No
Around the eyes	No
Other facial areas	No

Moreover, in September 2026, the FDA added stronger warnings about serious adverse reactions associated with Kybella use outside the submental region. Reported problems included nerve or muscle injury and, with use around the eyes, blurred or reduced vision.

Therefore, consumers should not assume that a drug approved for chin fat becomes automatically safe elsewhere.

How Does Kybella Treatment Work?

A qualified health care professional first evaluates whether the fullness under the chin is due to submental fat.

This step matters because other conditions can create a similar appearance.

Then, if treatment is appropriate, the professional administers multiple small injections throughout the selected submental area.

Treatment generally occurs over several sessions rather than in a single appointment.

The FDA-approved label allows up to six treatment sessions, with sessions spaced at least one month apart. However, the actual number depends on individual anatomy and treatment goals.

Importantly, patients should never buy deoxycholic acid online and attempt self-injection.

Correct placement requires detailed knowledge of facial and neck anatomy.

What Are the Common Side Effects?

Swelling is extremely common after Kybella treatment.

Other common reactions include bruising, pain, numbness, redness, and firmness in the treatment area.

In clinical trials, injection-site reactions occurred frequently. For example, the FDA label reports swelling in 87% of Kybella-treated subjects, pain in 70%, numbness in 66%, and bruising or hematoma in 72%.

Therefore, patients should expect a temporary local reaction rather than assume there is no recovery period.

Moreover, some symptoms can last longer than a few days.

The FDA label notes that numbness, swelling, pain, and firmness sometimes persist for more than 30 days.

What Serious Risks Should Patients Know About?

Although Kybella does not involve surgery, it is still a prescription injectable drug with potentially serious complications.

One important risk involves injury to the marginal mandibular nerve, which helps control movement around the lower face.

Consequently, nerve injury can cause facial weakness or an uneven smile.

Difficulty swallowing can also occur.

Additionally, the FDA warns about injection-site ulceration, tissue necrosis, infection, nodules, and larger masses. Some nodules or masses may persist and require medical treatment.

Therefore, provider experience matters considerably.

The label emphasizes that professionals need a detailed understanding of the anatomy around the jaw, muscles, salivary glands, blood vessels, nerves, and lymph nodes.

What Changed With the FDA Warning in 2026?

The September 2026 FDA update added an important new warning.

After reviewing postmarketing reports and medical literature, the FDA identified serious adverse reactions associated with injecting Kybella outside the approved under-chin area.

Consequently, the agency added new labeling that specifically recommends against such use.

The FDA also highlighted reports of persistent nodules and masses following deoxycholic acid injections. Some required medical intervention.

Therefore, the updated guidance reinforces an important principle: FDA approval for submental fat should not be interpreted as approval for broader body contouring.

Which Fat Dissolving Injections Are Not FDA Approved?

The market includes numerous products promoted as injection lipolysis or fat-dissolving injections.

The FDA has specifically identified products marketed under names such as Aqualyx, Lipodissolve, Lipo Lab, and Kabelline as examples of fat-dissolving injections that lack FDA approval.

Some contain phosphatidylcholine, sodium deoxycholate, or combinations sometimes described as PCDC injections.

However, the FDA has not evaluated these unapproved products for safety, effectiveness, or quality in the same way it evaluates approved drugs.

Moreover, the agency has received reports involving permanent scarring, serious infections, skin deformities, cysts, and painful deep nodules after unapproved injections.

That does not necessarily describe the regulatory status of a product in every country. However, it means the product does not have FDA approval in the United States.

Is FDA Approval the Same as Saying a Treatment Is Risk-Free?

No.

FDA approval means the agency reviewed evidence supporting a drug’s quality, safety, and effectiveness for its approved use.

However, every medical treatment carries potential risks.

Therefore, “FDA approved” should not be interpreted as “completely safe for everyone.”

Kybella, for example, remains contraindicated if an infection is present at the planned injection site. Additionally, people with certain swallowing problems, altered neck anatomy, previous procedures, or other medical factors may require special consideration.

A medical evaluation should therefore come before cosmetic treatment.

How Can You Check Whether a Fat Dissolving Injection Is FDA Approved?

Ask for the exact product name and active ingredient.

Then ask whether the provider plans to use it specifically for the FDA-approved submental indication.

Additionally, confirm that a properly licensed and trained health professional will administer the injections.

Be cautious if a provider advertises a product as “FDA-approved” while offering injections into numerous body areas.

The distinction between an approved drug and an approved use matters.

Likewise, avoid products purchased through social media, online marketplaces, or websites for self-injection.

The FDA specifically advises consumers not to purchase unapproved fat-dissolving injections online or inject themselves.

FDA-Approved Fat Dissolving Injections: The Final Take

The FDA-approved fat-dissolving injection category remains narrow.

Kybella and an FDA-approved generic deoxycholic acid injection can improve moderate-to-severe fullness caused by fat beneath the chin in adults.

However, FDA approval stops there.

These drugs are not approved for dissolving fat on the stomach, thighs, arms, back, flanks, or other body areas.

Moreover, the FDA strengthened warnings in 2026 after reports of serious complications from unapproved use outside the submental region.

Therefore, consumers should pay attention not only to the product being offered but also to where and how a provider intends to use it.

Ultimately, FDA-approved deoxycholic acid can offer a nonsurgical option for selected adults with submental fat, but it remains a medical treatment that requires appropriate patient selection, professional administration, and a clear understanding of its risks and limitations.